Stocktoria
Bayer Aktiengesellschaft BAYN.DE
Bayer Aktiengesellschaft (BAYN.DE) earns a Piotroski F-score of 6/9 (mixed financial health). It pays a dividend yielding 0.27% (safety: safe). FY2025 revenue was $45.6B at a -7.9% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 23 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
FAQ
Is BAYN.DE financially healthy?
Bayer Aktiengesellschaft's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak).
Does BAYN.DE pay a dividend, and is it safe?
Yes. Bayer Aktiengesellschaft pays a dividend yielding about 0.27% with a -3.5% payout ratio, rated “safe” for safety.
How profitable is BAYN.DE?
In FY2025, Bayer Aktiengesellschaft had a net margin of -7.9% and a return on equity of -14.0%.
Source: company filings via Yahoo Finance · DE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.